PepJunkie Home of the Peptonauts
More

Research

NA-Selank — living evidence map

The Atlas page holds the claims; this is how its evidence evolved.

Summary

The parent peptide, Selank, is the heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro, reported to have prolonged anti-anxiety and nootropic effects. · pmid:30255741

Identity

PubChem CID 133082488: N-Acetyl selank, C35H59N11O10, 793.9 g/mol. · pubchem:133082488

IUPAC name: (2S)-1-[2-[[(2S)-1-[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3R)-2-acetamido-3-hydroxybutanoyl]amino]-6-aminohexanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic acid. · pubchem:133082488


Where the evidence actually sits

Preclinical only100%

Proportion of the 1 claim about NA-Selank standing at each tier. Community volume is shown on the Consensus tab beside this and is never averaged into it.


Living evidence history

Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity. (2018) · preclinical20182018

1 resolved citation, oldest to newest, coloured by tier. Retractions and contradictions land here as they are recorded.


Structure

No structure representation on record. PepJunkie draws only what an authoritative record supplies; for a peptide that is the residue sequence, and none has been curated for NA-Selank yet.


Dose evidence, rung by rung

No established safe human dose. Nothing on file establishes one. That is a statement about the evidence PepJunkie holds, not a promise about the molecule.

  1. Approved-label dose · a resolved regulatory document names a labelled dose

    nothing resolved on this rung

  2. Studied human doses · resolved human studies at the established tier

    nothing resolved on this rung

  3. Observational evidence · resolved human data at the emerging tier: thin, or contested

    nothing resolved on this rung

  4. Community-reported protocols · protocol propositions from distinct members, counted once per human

    nothing resolved on this rung

  5. Preclinical evidence · resolved animal, cell or mechanistic work
    • Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity. · pmid 30255741 · 2018

1 resolved citation, 0 unresolved (an unresolved citation lends nothing). Community volume is its own rung and is never averaged into the evidence rungs.